The James Outpatient Care
The James Outpatient Care is located south of the Kenny and Carmack roads intersection in the Carmenton innovation district. The $356.5 million project includes outpatient operating rooms, interventional radiology rooms, extended recovery unit, pre-anesthesia center, a diagnostic imaging center, pharmacy, hematology clinic, genitourinary (GU) clinic, infusion and medical office and support spaces. The project also adds a 640-space James Outpatient Care parking garage. The approximately 385,000 square foot cancer-focused facility will include central Ohio’s first proton therapy treatment facility in partnership with Nationwide Children’s Hospital. The building joins the Pelotonia Research Center and an Energy Advancement and Innovation Center as the first three major projects envisioned for Carmenton.
Learn more about how Ohio State in investing in the spaces and places that empower collaboration by visiting Ohio State Environments.
Proton Therapy Center
The proton therapy facility, in partnership with Nationwide Children’s Hospital, will be the first of its kind in central Ohio. Proton therapy is an advanced type of radiation treatment that uses protons (positively charged particles) instead of x-rays to kill cancer cells. A machine delivers a high-energy proton beam painlessly through the skin from outside the body.
Proton therapy is expected to utilize 65,000 square feet and account for approximately $105 million of the overall project budget. Nationwide Children’s has committed up to 50% of the expected proton center project cost.
- BOT Professional Services ApprovalNovember 2018Design/BiddingDecember 2018 – July 20202019
- BOT Construction Approval - GarageNovember 20192020
- BoT Construction Approval - Partial (Proton)February 2020ConstructionJuly 2020 – April 2023BoT Final Construction AppovalAugust 20202023
- Facility Opening - GarageJuly 2023Facility Opening - Outpatient CareJuly 2023Facility Opening - ProtonOctober 2023
Study/Planning AE: Perkins+Will
AE/Design Architect: Perkins+Will
Boldt-Linbeck (joint venture)